Crowdsourcing to better forecast drug approvals
Researchers launched an in-house Data Science and Artificial Intelligence (DSAI) challenge to beat MIT’s machine-learning models for predicting clinical trial outcomes. The results are now available.
Researchers launched an in-house Data Science and Artificial Intelligence (DSAI) challenge to beat MIT’s machine-learning models for predicting clinical trial outcomes. The results are now available.
By
Addressing climate change means matching data with targeted action. Tracking the right metrics, and using them the right way, is essential.
By
Labor, health, and environmental concerns threaten the might of meat. But alternative foods face major challenges.
By
The project is charting a course toward more rigorous, coherent methods for ESG integration, with four key goals that are relevant to asset owners and managers, as well as regulators.
By
Integrating robots into a manufacturing system is often prohibitively expensive. A new approach could change that.
By
Companies make common data science mistakes. Here’s an expert’s guide to what they are and how to avoid them.
By
Online interface simulates 100 years of energy, land and climate data in less than one second to identify solutions to limit warming to within 2 degrees Celsius by 2100
By
MIT Sloan and CSAIL researchers apply artificial intelligence techniques to one of the largest datasets of clinical trial outcomes to handicap the drug and device approval process
By
National Capital Protocol Toolkit (NCT) offers companies a structured process to identify key business risks and opportunities in their management of natural resources.
By
In a new book, MIT roboticist Daniela Rus looks at the powers and limitations of robots and how humans can work with them to unlock new capabilities.